Neurocrine Biosciences (NBIX) Net Margin Growth (3y) (2013 - 2026)
Neurocrine Biosciences (NBIX) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,620.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -98.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4,358.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,235.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -100.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4,252.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -404.00 |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 2,318.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,252.00 |
| Dec 31, 2025 | -252.00 |
| Sep 30, 2025 | 870.00 |
| Jun 30, 2025 | 10,014.00 |
| Mar 31, 2025 | -310.00 |
| Dec 31, 2024 | 1,876.00 |
| Sep 30, 2024 | 1,326.00 |
| Jun 30, 2024 | -363.00 |
| Mar 31, 2024 | -514.00 |
| Dec 31, 2023 | -11,167.00 |
| Sep 30, 2023 | 3,894.00 |
| Jun 30, 2023 | -523.00 |
| Mar 31, 2023 | -3,399.00 |
| Dec 31, 2022 | 767.00 |
| Sep 30, 2022 | -656.00 |
| Jun 30, 2022 | -11,246.00 |
| Mar 31, 2022 | 7,825.00 |
| Dec 31, 2021 | -1,661.00 |
| Sep 30, 2021 | -2,585.00 |
| Jun 30, 2021 | 2,074.00 |